Cargando…
Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals
Background: Previously we showed that the release properties of a liposomal ciprofloxacin (CFI) formulation could be attenuated by incorporation of drug nanocrystals within the vesicles. Rather than forming these drug nanocrystals during drug loading, they were created post manufacture simply by fre...
Autores principales: | Cipolla, David, Wu, Huiying, Gonda, Igor, Chan, Hak-Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685509/ https://www.ncbi.nlm.nih.gov/pubmed/26469306 http://dx.doi.org/10.1089/jamp.2015.1241 |
Ejemplares similares
-
Aerosol Performance and Long-Term Stability of Surfactant-Associated Liposomal Ciprofloxacin Formulations with Modified Encapsulation and Release Properties
por: Cipolla, David, et al.
Publicado: (2014) -
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug
por: Cipolla, David, et al.
Publicado: (2016) -
Development of Liposomal Ciprofloxacin to Treat Lung Infections
por: Cipolla, David, et al.
Publicado: (2016) -
Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
por: Serisier, David J, et al.
Publicado: (2013) -
The potential of liposome–encapsulated ciprofloxacin as a tularemia therapy
por: Hamblin, Karleigh A., et al.
Publicado: (2014)